Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Filed Nov 7, 2011 · 10-Q · 38 days after period end · 0001193125-11-298587
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $2.64M | $1.28M |
| Net Income | -$4.54M | -$1.41M |
| EPS Diluted | -$0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 7, 2011 · 38 d after period end
